Basic Aspects of Ghrelin Action

Abizaid, 2006, Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite, J. Clin. Invest., 116, 3229, 10.1172/JCI29867 Adams, 1995, The growth hormone secretagogue, L‐692,429, induces phosphatidylinositol hydrolysis and hormone secretion by human pituitary tumors, Biochem. Biophys. Res. Commun., 208, 555, 10.1006/bbrc.1995.1374 Andersson, 2004, AMP‐activated protein kinase plays a role in the control of food intake, J. Biol. Chem., 279, 12005, 10.1074/jbc.C300557200 Andreis, 2003, Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: Evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells, FEBS Lett., 536, 17317, 10.1016/S0014-5793(03)00051-6 Ariyasu, 2005, Transgenic mice overexpressing des‐acyl ghrelin show small phenotype, Endocrinology, 146, 355, 10.1210/en.2004-0629 Asakawa, 2001, Ghrelin is an appetite‐stimulatory signal from stomach with structural resemblance to motilin, Gastroenterology, 120, 337, 10.1053/gast.2001.22158 Asakawa, 2005, Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin, Gut, 54, 18, 10.1136/gut.2004.038737 Avallone, 2006, A Growth hormone‐releasing peptide that binds scavenger receptor CD36 and ghrelin receptor upregulates ABC sterol transporters and cholesterol efflux in macrophages through a PPAR{gamma}‐dependent pathway, Mol. Endocrinol., 20, 3165, 10.1210/me.2006-0146 Baiguera, 2004, Ghrelin inhibits in vitro angiogenic activity of rat brain microvascular endothelial cells, Int. J. Mol. Med., 14, 849 Baldanzi, 2002, Ghrelin and des‐acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3‐kinase/AKT, J. Cell Biol., 159, 1029, 10.1083/jcb.200207165 Barazzoni, 2005, Ghrelin regulates mitochondrial‐lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle, Am. J. Physiol. Endocrinol. Metab., 288, E228, 10.1152/ajpendo.00115.2004 Bedendi, 2003, Cardiac effects of ghrelin and its endogenous derivatives des‐octanoyl ghrelin and des‐Gln14‐ghrelin, Eur. J. Pharmacol., 476, 87, 10.1016/S0014-2999(03)02083-1 Bednarek, 2000, Structure‐function studies on the new growth hormone‐releasing peptide, ghrelin: Minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a, J. Med. Chem., 43, 4370, 10.1021/jm0001727 Bennett, 1997, Hypothalamic growth hormone secretagogue‐receptor (GHS‐R) expression is regulated by growth hormone in the rat, Endocrinology, 138, 4552, 10.1210/en.138.11.4552 Bodart, 2002, CD36 mediates the cardiovascular action of growth hormone‐releasing peptides in the heart, Circ. Res., 90, 844, 10.1161/01.RES.0000016164.02525.B4 Bondensgaard, 2004, Recognition of privileged structures by G‐protein coupled receptors, J. Med. Chem., 47, 888, 10.1021/jm0309452 Bowers, 1980, Structure‐activity relationships of a synthetic pentapeptide that specifically releases growth hormone in vitro, Endocrinology, 10, 663, 10.1210/endo-106-3-663 Bowers, 1984, On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone, Endocrinology, 114, 1537, 10.1210/endo-114-5-1537 Bresciani, 2004, Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites, Neuroendocrinology, 80, 52, 10.1159/000080793 Broglio, 2001, Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans, J. Clin. Endocrinol. Metab., 86, 5083, 10.1210/jc.86.10.5083 Brywe, 2005, Growth hormone‐releasing peptide hexarelin reduces neonatal brain injury and alters Akt/glycogen synthase kinase‐3β phosphorylation, Endocrinology, 146, 4665, 10.1210/en.2005-0389 Calapai, 1998, Effects of intracerebroventricular leptin administration on food intake, body weight gain and diencephalic nitric oxide synthase activity in the mouse, Br. J. Pharmacol., 125, 798, 10.1038/sj.bjp.0702121 Calapai, 1999, Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis, J. Clin. Invest., 104, 975, 10.1172/JCI5867 Camina, 2004, Desensitization and endocytosis mechanisms of ghrelin‐activated growth hormone secretagogue receptor 1a, Endocrinology, 145, 930, 10.1210/en.2003-0974 Caminos, 2005, The endogenous growth hormone secretagogue (ghrelin) is synthesized and secreted by chondrocytes, Endocrinology, 146, 1285, 10.1210/en.2004-1379 Carreira, 2004, Agonist‐specific coupling of growth hormone secretagogue receptor type 1a to different intracellular signaling systems. Role of adenosine, Neuroendocrinology, 79, 13, 10.1159/000076042 Carreira, 2006, Adenosine does not bind to the growth hormone secretagogue receptor type‐1a (GHS‐R1a), J. Endocrinol., 191, 147, 10.1677/joe.1.06714 Cassoni, 2001, Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines, J. Clin. Endocrinol. Metab., 84, 1738, 10.1210/jc.86.4.1738 Cassoni, 2004, Expression of ghrelin and biological activity of specific receptors for ghrelin and des‐acyl ghrelin in human prostate neoplasms and related cell lines, Eur. J. Endocrinol., 150, 173, 10.1530/eje.0.1500173 Castrillo, 2004, Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation, Annu. Rev. Cell Dev. Biol., 20, 455, 10.1146/annurev.cellbio.20.012103.134432 Chen, 1995, Effects of growth hormone‐releasing peptide‐2 (GHRP‐2) on membrane Ca2+ permeability in cultured ovine somatotrophs, J. Neuroendocrinol., 7, 179, 10.1111/j.1365-2826.1995.tb00745.x Chen, 1990, Two types of voltage‐dependent calcium current in rat somatotrophs are reduced by somatostatin, J. Physiol., 425, 29, 10.1113/jphysiol.1990.sp018090 Chen, 1996, Signal transduction systems employed by synthetic GH‐releasing peptides in somatotrophs, J. Endocrinol., 148, 381, 10.1677/joe.0.1480381 Chen, 2005, Des‐acyl ghrelin acts by CRF type 2 receptors to disrupt fasted stomach motility in conscious rats, Gastroenterology, 129, 8, 10.1053/j.gastro.2005.04.015 Conconi, 2004, Ghrelin inhibits FGF‐2‐mediated angiogenesis in vitro and in vivo, Peptides, 25, 2179, 10.1016/j.peptides.2004.08.011 Cunha, 2002, Ghrelin and growth hormone (GH) secretagogues potentiate GH‐releasing hormone (GHRH)‐induced cyclic adenosine 3′,5′‐monophosphate production in cells expressing transfected GHRH and GH secretagogue receptors, Endocrinology, 143, 4570, 10.1210/en.2002-220670 Dass, 2003, Growth hormone secretagogue receptors in rat and human gastrointestinal tract and the effects of ghrelin, Neuroscience, 120, 443, 10.1016/S0306-4522(03)00327-0 Deghenghi, 2001, Cortistatin, but not somatostatin, binds to growth hormone secretagogue (GHS) receptors of human pituitary gland, J. Endocrinol. Invest., 24, RC1, 10.1007/BF03343800 Delgado‐Rubin de Celix, 2006, Growth hormone releasing peptide‐6 acts as a survival factor in glutamate‐induced excitotoxicity, J. Neurochem., 99, 839, 10.1111/j.1471-4159.2006.04122.x Delhanty, 2006, Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen‐activated protein kinase (MAPK)/phosphoinositide 3‐kinase (PI3K) pathways in the absence of GHS‐R1a, J. Endocrinol., 188, 37, 10.1677/joe.1.06404 De Vriese, 2005, Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation, Endocrinology, 146, 1514, 10.1210/en.2004-0964 Dixit, 2004, Ghrelin inhibits leptin‐ and activation‐induced proinflammatory cytokine expression by human monocytes and T cells, J. Clin. Invest., 114, 57, 10.1172/JCI200421134 Dumont, 2001, Crosstalk and specificity in signalling. Are we crosstalking ourselves into general confusion?, Cell. Signal., 13, 457, 10.1016/S0898-6568(01)00168-1 Duxbury, 2003, Ghrelin promotes pancreatic adenocarcinoma cellular proliferation and invasiveness, Biochem. Biophys. Res. Commun., 309, 464, 10.1016/j.bbrc.2003.08.024 Druce, 2005, Ghrelin increases food intake in obese as well as lean subjects, Int. J. Obes. (Lond.), 29, 1130, 10.1038/sj.ijo.0803001 Feighner, 1998, Structural requirements for the activation of the human growth hormone secretagogue receptor by peptide and nonpeptide secretagogues, Mol. Endocrinol., 12, 137, 10.1210/me.12.1.137 Frago, 2002, Growth hormone (GH) and GH‐releasing peptide‐6 increase brain insulin‐like growth factor‐I expression and activate intracellular signaling pathways involved in neuroprotection, Endocrinology, 143, 4113, 10.1210/en.2002-220261 Frago, 2005, Growth hormone‐releasing peptide‐6 increases insulin‐like growth factor‐I mRNA levels and activates Akt in RCA‐6 cells as a model of neuropeptide Y neurones, J. Neuroendocrinol., 17, 701, 10.1111/j.1365-2826.2005.01347.x Gauna, 2004, Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity, J. Clin. Endocrinol. Metab., 89, 5035, 10.1210/jc.2004-0363 Gauna, 2005, Ghrelin stimulates, whereas des‐octanoyl ghrelin inhibits, glucose output by primary hepatocytes, J. Clin. Endocrinol. Metab., 90, 1055, 10.1210/jc.2004-1069 Gaskin, 2003, Ghrelin‐induced feeding is dependent on nitric oxide, Peptides, 24, 913, 10.1016/S0196-9781(03)00160-8 Gaytan, 2003, Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary, J. Clin. Endocrinol. Metab., 88, 879, 10.1210/jc.2002-021196 Gaytan, 2004, Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors, J. Clin. Endocrinol. Metab., 89, 400, 10.1210/jc.2003-031375 Gaytan, 2005, Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives and ovarian tumors, J. Clin. Endocrinol. Metab., 90, 1798, 10.1210/jc.2004-1532 Ghe, 2002, The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU‐1 lung carcinoma cells, Endocrinology, 143, 484, 10.1210/en.143.2.484 Gnanapavan, 2002, The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS‐R, in humans, J. Clin. Endocrinol. Metab., 87, 2988, 10.1210/jc.87.6.2988 Granado, 2005, Ghrelin receptor agonist GHRP‐2 prevents arthritis‐induced increase in E3 ubiquitin‐ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle, Am. J. Physiol. Endocrinol. Metab., 289, E1007, 10.1152/ajpendo.00109.2005 Grove, 2005, Is ghrelin a signal for the development of metabolic systems?, J. Clin. Invest., 115, 3393, 10.1172/JCI27211 Guan, 1997, Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues, Brain Res. Mol. Brain Res., 48, 23, 10.1016/S0169-328X(97)00071-5 Hardie, 2004, The AMP‐activated protein kinase pathway‐new players upstream and downstream, J. Cell. Sci., 117, 5479, 10.1242/jcs.01540 Herrington, 1994, Growth hormone‐releasing hexapeptide elevates intracellular calcium in rat somatotropes by two mechanisms, Endocrinology, 135, 1100, 10.1210/en.135.3.1100 Holst, 2004, Constitutive ghrelin receptor activity as a signaling set‐point in appetite regulation, Trends Pharmacol. Sci., 25, 113, 10.1016/j.tips.2004.01.010 Holst, 2006, Ghrelin receptor mutations–too little height and too much hunger, J. Clin. Invest., 116, 637, 10.1172/JCI27999 Holst, 2003, High constitutive signaling of the ghrelin receptor‐identification of a potent inverse agonist, Mol. Endocrinol., 17, 2201, 10.1210/me.2003-0069 Holst, 2004, Common structural basis for constitutive activity of the ghrelin receptor family, J. Biol. Chem., 279, 53806, 10.1074/jbc.M407676200 Holst, 2005, Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling, Mol. Endocrinol., 19, 2400, 10.1210/me.2005-0059 Holst, 2006, Ghrelin receptor inverse agonists: Identification of an active peptide core and its interaction epitopes on the receptor, Mol. Pharmacol., 70, 936, 10.1124/mol.106.024422 Howard, 1996, A receptor in pituitary and hypothalamus that functions in growth hormone release, Science, 273, 974, 10.1126/science.273.5277.974 Horikawa, 2000, Regulation of pituitary growth hormone‐secretagogue and growth hormone‐releasing hormone receptor RNA expression in young Dwarf rats, Endocr. J., 47, S53, 10.1507/endocrj.47.SupplMarch_S53 Iglesias, 2004, Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes, Cardiovasc. Res., 62, 481, 10.1016/j.cardiores.2004.01.024 Jeffery, 2002, Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines, J. Endocrinol., 172, R7, 10.1677/joe.0.172R007 Jiang, 2006, Ghrelin amplifies dopamine signaling by cross talk involving formation of growth hormone secretagogue receptor/dopamine receptor subtype 1 heterodimers, Mol. Endocrinol., 20, 1772, 10.1210/me.2005-0084 Johansson, 2005, Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor, Biochem. Pharmacol., 70, 598, 10.1016/j.bcp.2005.05.023 Kaji, 2001, Hormonal regulation of the human ghrelin receptor gene transcription, Biochem. Biophys. Res. Commun., 284, 660, 10.1006/bbrc.2001.5035 Kamegai, 1998, Growth hormone‐dependent regulation of pituitary GH secretagogue receptor (GHS‐R) mRNA levels in the spontaneous dwarf rat, Neuroendocrinology, 68, 312, 10.1159/000054379 Kamegai, 1999, Growth hormone‐releasing hormone receptor (GHRH‐R) and growth hormone secretagogue receptor (GHS‐R) mRNA levels during postnatal development in male and female rats, J. Neuroendocrinol., 11, 299, 10.1046/j.1365-2826.1999.00330.x Kamegai, 2001, Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression, J. Neuroendocrinol., 13, 275, 10.1046/j.1365-2826.2001.00623.x Kamegai, 2005, Insulin‐like growth factor‐I down‐regulates ghrelin receptor (growth hormone secretagogue receptor) expression in the rat pituitary, Regul. Pept., 127, 203, 10.1016/j.regpep.2004.12.001 Katayama, 2000, Developmentally and regionally regulated expression of growth hormone secretagogue receptor mRNA in rat brain and pituitary gland, Neuroendocrinology, 72, 333, 10.1159/000054602 Kato, 1999, The effect of GHRP‐6 on the intracellular Na+ concentration of rat pituitary cells in primary culture, J. Neuroendocrinol., 11, 795, 10.1046/j.1365-2826.1999.00394.x Kim, 2004, The mitogenic and antiapoptotic actions of ghrelin in 3T3‐L1 adipocytes, Mol. Endocrinol., 18, 2291, 10.1210/me.2003-0459 Kineman, 1999, Growth hormone (GH)‐releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels, Endocrinology, 140, 3581, 10.1210/en.140.8.3581 Kojima, 1999, Ghrelin is a growth‐hormone‐releasing acylated peptide from stomach, Nature, 402, 656, 10.1038/45230 Kojima, 2001, Ghrelin: Discovery of the natural endogenous ligand for the growth hormone secretagogue receptor, Trends Endocrinol. Metab., 12, 118, 10.1016/S1043-2760(00)00362-3 Kola, 2005, Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP‐activated protein kinase, J. Biol. Chem., 280, 25196, 10.1074/jbc.C500175200 Kohno, 2003, Ghrelin directly interacts with neuropeptide‐Y‐containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N‐type channel‐dependent mechanisms and cross‐talk with leptin and orexin, Diabetes, 52, 948, 10.2337/diabetes.52.4.948 Korbonits, 2004, Ghrelin: A hormone with multiple functions, Front. Neuroendocrinol., 25, 27, 10.1016/j.yfrne.2004.03.002 Laferrere, 2005, Growth hormone releasing peptide‐2 (GHRP‐2), like ghrelin, increases food intake in healthy men, J. Clin. Endocrinol. Metab., 90, 611, 10.1210/jc.2004-1719 Lee, 2003, Transcriptional repression of atherogenic inflammation: Modulation by PPARdelta, Science, 302, 453, 10.1126/science.1087344 Li, 2004, Ghrelin inhibits proinflammatory responses and nuclear factor‐kappaB activation in human endothelial cells, Circulation, 109, 2221, 10.1161/01.CIR.0000127956.43874.F2 Long, 2006, AMP‐activated protein kinase signaling in metabolic regulation, J. Clin. Invest., 116, 1776, 10.1172/JCI29044 Luttrell, 2002, The role of beta‐arrestins in the termination and transduction of G‐protein‐coupled receptor signals, J. Cell. Sci., 115, 455, 10.1242/jcs.115.3.455 Maccarinelli, 2005, Ghrelin regulates proliferation and differentiation of osteoblastic cells, J. Endocrinol., 184, 249, 10.1677/joe.1.05837 Mazzocchi, 2004, Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK‐mediated proliferogenic and antiapoptotic effects, Peptides, 25, 1269, 10.1016/j.peptides.2004.05.011 McKee, 1997, Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors, Mol. Endocrinol., 11, 415, 10.1210/me.11.4.415 Morley, 1999, Leptin and neuropeptide Y (NPY) modulate nitric oxide synthase: Further evidence for a role of nitric oxide in feeding, Peptides, 20, 595, 10.1016/S0196-9781(99)00012-1 Mousseaux, 2006, Regulation of ERK1/2 activity by ghrelin‐activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway, Br. J. Pharmacol., 148, 350, 10.1038/sj.bjp.0706727 Muccioli, 1998, Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland, J. Endocrinol., 157, 99, 10.1677/joe.0.1570099 Muccioli, 2001, Binding of 125I‐labeled ghrelin to membranes from human hypothalamus and pituitary gland, J. Endocrinol. Invest., 24, RC7, 10.1007/BF03343831 Muccioli, 2004, Ghrelin and des‐acyl ghrelin both inhibit isoproterenol‐induced lipolysis in rat adipocytes via a non‐type 1a growth hormone secretagogue receptor, Eur. J. Pharmacol., 498, 27, 10.1016/j.ejphar.2004.07.066 Murata, 2002, Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells, J. Biol. Chem., 277, 5667, 10.1074/jbc.M103898200 Nakazato, 2001, A role for ghrelin in the central regulation of feeding, Nature, 409, 194, 10.1038/35051587 Nagaya, 2004, Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure, Circulation, 110, 3674, 10.1161/01.CIR.0000149746.62908.BB Nass, 2000, High plasma growth hormone (GH) levels inhibit expression of GH secretagogue receptor messenger ribonucleic acid levels in the rat pituitary, Endocrinology, 141, 2084, 10.1210/en.141.6.2084 Neary, 2004, Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo‐controlled trial, J. Clin. Endocrinol. Metab., 89, 2832, 10.1210/jc.2003-031768 Nogueiras, 2004, Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin, Diabetes, 53, 2552, 10.2337/diabetes.53.10.2552 Ong, 1998, Identification of a pituitary growth hormone‐releasing peptide (GHRP) receptor subtype by photoaffinity labeling, Endocrinology, 139, 432, 10.1210/en.139.1.432 Pantel, 2006, Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature, J. Clin. Invest., 116, 760, 10.1172/JCI25303 Patchett, 1995, Design and biological activities of L‐163,191 (MK‐0677): A potent, orally active growth hormone secretagogue, Proc. Natl. Acad. Sci. USA, 92, 7001, 10.1073/pnas.92.15.7001 Pedretti, 2006, Construction of human ghrelin receptor (hGHS‐R1a) model using a fragmental prediction approach and validation through docking analysis, J. Med. Chem., 49, 3077, 10.1021/jm058053k Peng, 2001, The growth hormone (GH)‐axis of GH receptor/binding protein gene‐disrupted and metallothionein‐human GH‐releasing hormone transgenic mice: Hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback, Endocrinology, 142, 1117, 10.1210/en.142.3.1117 Petersenn, 2001, Genomic structure and transcriptional regulation of the human growth hormone secretagogue receptor, Endocrinology, 142, 2649, 10.1210/en.142.6.2649 Qader, 2005, Ghrelin activates neuronal constitutive nitric oxide synthase in pancreatic islet cells while inhibiting insulin release and stimulating glucagon release, Regul. Pept., 128, 51, 10.1016/j.regpep.2004.12.018 Rossi, 2006, Ghrelin inhibits angiotensin II‐induced migration of human aortic endothelial cells, Atherosclerosis, 192, 291, 10.1016/j.atherosclerosis.2006.07.021 Schmid, 2005, Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls, Neuropsychopharmacology, 30, 1187, 10.1038/sj.npp.1300670 Shimada, 1998, Mice lacking melanin‐concentrating hormone are hypophagic and lean, Nature, 396, 670, 10.1038/25341 Shuto, 2002, Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity, J. Clin. Invest., 109, 1429, 10.1172/JCI0213300 Smith, 1993, A nonpeptidyl growth hormone secretagogue, Science, 260, 1640, 10.1126/science.8503009 Smith, 2000, Adenosine: A partial agonist of the growth hormone secretagogue receptor, Biochem. Biophys. Res. Commun., 276, 1306, 10.1006/bbrc.2000.3610 Smith, 2005, Developments in ghrelin biology and potential clinical relevance, Trends Endocrinol. Metab., 16, 436, 10.1016/j.tem.2005.09.004 Sun, 2003, Deletion of ghrelin impairs neither growth nor appetite, Mol. Cell Biol., 23, 7973, 10.1128/MCB.23.22.7973-7981.2003 Sun, 2004, Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor, Proc. Natl. Acad. Sci. USA, 101, 4679, 10.1073/pnas.0305930101 Tannenbaum, 1998, Expression of growth hormone secretagogue‐receptors by growth hormone‐releasing hormone neurons in the mediobasal hypothalamus, Endocrinology, 139, 4420, 10.1210/en.139.10.4420 Tamura, 2000, Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression, J. Neuroendocrinol., 12, 481, 10.1046/j.1365-2826.2000.00446.x Thomas, 2000, Glucocorticoid regulation of growth hormone (GH) secretagogue‐induced growth responses and GH secretagogue receptor expression in the rat, Growth Horm. IGF Res., 10, 45, 10.1054/ghir.1999.0138 Thompson, 2004, Ghrelin and des‐octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor, Endocrinology, 145, 234, 10.1210/en.2003-0899 Torsello, 2002, Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo, Endocrinology, 143, 1968, 10.1210/en.143.5.1968 Toshinai, 2006, Des‐acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor, Endocrinology, 147, 2306, 10.1210/en.2005-1357 Tullin, 2000, Adenosine is an agonist of the growth hormone secretagogue receptor, Endocrinology, 141, 3397, 10.1210/en.141.9.3397 Tschop, 2000, Ghrelin induces adiposity in rodents, Nature, 407, 908, 10.1038/35038090 van der Lely, 2004, Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin, Endocr. Rev., 25, 426, 10.1210/er.2002-0029 Wallenius, 2001, Liver‐derived IGF‐I regulates GH secretion at the pituitary level in mice, Endocrinology, 142, 114762, 10.1210/en.142.11.4762 Wang, 2004, Ghrelin receptor gene: Identification of several sequence variants in extremely obese children and adolescents, healthy normal‐weight and underweight students, and children with short normal stature, J. Clin. Endocrinol. Metab., 89, 157, 10.1210/jc.2003-031395 Welch, 2003, PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN‐gamma target genes in macrophages, Proc. Natl. Acad. Sci. USA, 100, 6712, 10.1073/pnas.1031789100 Willesen, 1999, Co‐localization of growth hormone secretagogue receptor and NPY mRNA in the arcuate nucleus of the rat, Neuroendocrinology, 70, 306, 10.1159/000054491 Wortley, 2004, Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference, Proc. Natl. Acad. Sci. USA, 101, 8227, 10.1073/pnas.0402763101 Wortley, 2005, Absence of ghrelin protects against early‐onset obesity, J. Clin. Invest., 115, 3573, 10.1172/JCI26003 Wren, 2000, The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion, Endocrinology, 141, 4325, 10.1210/en.141.11.4325 Wren, 2001, Ghrelin enhances appetite and increases food intake in humans, J. Clin. Endocrinol. Metab., 86, 5992, 10.1210/jc.86.12.5992 Wren, 2001, Ghrelin causes hyperphagia and obesity in rats, Diabetes, 50, 2540, 10.2337/diabetes.50.11.2540 Wu, 1996, The effects of GH‐releasing peptide‐6 (GHRP‐6) and GHRP‐2 on intracellular adenosine 3′,5′‐monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs, J. Endocrinol., 148, 197, 10.1677/joe.0.1480197 Wynne, 2005, Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: A randomized, placebo‐controlled trial, J. Am. Soc. Nephrol., 16, 2111, 10.1681/ASN.2005010039 Xie, 2004, Ghrelin and truncated ghrelin variant plasmid vectors administration into skeletal muscle augments long‐term growth in rats, Domest. Anim. Endocrinol., 27, 155, 10.1016/j.domaniend.2004.03.005 Zhao, 2001, Signal transduction pathways mediating neurotensin‐stimulated interleukin‐8 expression in human colonocytes, J. Biol. Chem., 276, 44464, 10.1074/jbc.M104942200 Zhao, 2005, Neurotensin stimulates interleukin‐8 expression through modulation of I kappa. B alpha phosphorylation and p65 transcriptional activity: Involvement of protein kinase C alpha, Mol. Pharmacol., 67, 2025, 10.1124/mol.104.010801 Zhao, 2006, Ghrelin stimulates interleukin‐8 gene expression through protein kinase C‐mediated NF‐kappaB pathway in human colonic epithelial cells, J. Cell Biochem., 97, 1317, 10.1002/jcb.20744 Zhou, 1997, A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse), Proc. Natl. Acad. Sci. USA, 94, 13215, 10.1073/pnas.94.24.13215 Zigman, 2005, Mice lacking ghrelin receptors resist the development of diet‐induced obesity, J. Clin. Invest., 115, 3564, 10.1172/JCI26002 Zhu, 2006, On the processing of proghrelin to ghrelin, J. Biol. Chem., 281, 38867, 10.1074/jbc.M607955200 Granata, 2007, Acetylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta cells and human islets. Involvement of cAMP/PKA, ERK1/2 and PI3K/AKT signaling, Endocrinology, 148, 512, 10.1210/en.2006-0266 Iantorno, 2007, Ghrelin has novel vascular actions that mimic only PI 3‐kinase‐dependent insulin‐stimulated production of nitric oxide (NO) but not MAP‐kinase‐dependent insulin‐stimulated secretion of ET‐1 from endothelial cells, Am. J. Physiol. Endocrinol. Metab., 292, E756, 10.1152/ajpendo.00570.2006